These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1355745)
1. An evaluation of the antihistamine activity of acrivastine and its onset in human skin. Manna VK; Marks P; Gibson JR J Int Med Res; 1992 Apr; 20(2):106-11. PubMed ID: 1355745 [TBL] [Abstract][Full Text] [Related]
2. Acrivastine--an evaluation of initial and peak activity in human skin. Marks P; Manna VK; Gibson JR J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999 [TBL] [Abstract][Full Text] [Related]
3. Effects of acrivastine and terfenadine on skin reactivity to histamine. Leynadier F; Murrieta M; Dry J; Colin JN; Gillotin C; Steru D Ann Allergy; 1994 Jun; 72(6):520-4. PubMed ID: 7911286 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria. Neittaanmäki H; Fräki JE; Gibson JR Dermatologica; 1988; 177(2):98-103. PubMed ID: 2901993 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the onset of H1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers. Rolan PE; Adams J; Posner J J Int Med Res; 1989; 17 Suppl 2():35B-39B. PubMed ID: 2570000 [TBL] [Abstract][Full Text] [Related]
6. Time of onset of action of acrivastine in the skin of pollen-allergic subjects. A double-blind, randomized, placebo-controlled comparative study. Petersen LJ; Bindslev-Jensen C; Poulsen LK; Malling HJ Allergy; 1994 Jan; 49(1):27-30. PubMed ID: 7911009 [TBL] [Abstract][Full Text] [Related]
7. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin. Sansom JE; Brooks J; Burton JL; Archer CB Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766 [TBL] [Abstract][Full Text] [Related]
8. The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers. Rolan PE; Phillips S; Adams J; Posner J Eur J Clin Pharmacol; 1990; 39(3):311-3. PubMed ID: 1979541 [TBL] [Abstract][Full Text] [Related]
9. The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effects. Cohen AF; Hamilton M; Philipson R; Peck AW Clin Pharmacol Ther; 1985 Oct; 38(4):381-6. PubMed ID: 3840066 [TBL] [Abstract][Full Text] [Related]
10. The butterbur extract petasin has no effect on skin test reactivity induced by different stimuli: a randomized, double-blind crossover study using histamine, codeine, methacholine, and aeroallergen solutions. Gex-Collet C; Imhof L; Brattström A; Pichler WJ; Helbling A J Investig Allergol Clin Immunol; 2006; 16(3):156-61. PubMed ID: 16784008 [TBL] [Abstract][Full Text] [Related]
11. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses. Bayramgürler D; Bilen N; Apaydýn R; Altintaş L; Sal G; Dökmeci S; Utkan T Clin Exp Dermatol; 1999 Sep; 24(5):407-11. PubMed ID: 10564333 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine. Ballmer-Weber BK; Gex-Collet C; Wüthrich B J Investig Allergol Clin Immunol; 1999; 9(6):351-5. PubMed ID: 10664928 [TBL] [Abstract][Full Text] [Related]
13. Initiation of the effects of acrivastine and cetirizine on histamine-induced wheals and itch in human skin. Lahti A; Haapaniemi T Acta Derm Venereol; 1993 Oct; 73(5):350-1. PubMed ID: 7904400 [TBL] [Abstract][Full Text] [Related]
14. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria. van Joost T; Blog FB; Westerhof W; Jansen FC; Starink TM; den Boer MS; Kuneman JJ; Harvey SG; Gibson JR J Int Med Res; 1989; 17 Suppl 2():14B-17B. PubMed ID: 2569995 [TBL] [Abstract][Full Text] [Related]
15. Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders. Brogden RN; McTavish D Drugs; 1991 Jun; 41(6):927-40. PubMed ID: 1715267 [TBL] [Abstract][Full Text] [Related]
16. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria. Leyh F; Harvey SG; Gibson JR; Manna VK J Int Med Res; 1989; 17 Suppl 2():22B-24B. PubMed ID: 2569997 [TBL] [Abstract][Full Text] [Related]
17. Acrivastine versus terfenadine in the treatment of symptomatic dermographism--a double-blind, placebo-controlled study. Boyle J; Marks P; Gibson JR J Int Med Res; 1989; 17 Suppl 2():9B-13B. PubMed ID: 2570004 [TBL] [Abstract][Full Text] [Related]
18. Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled study. Kobza Black A; Aboobaker J; Gibson JR; Harvey SG; Marks P Acta Derm Venereol; 1988; 68(6):541-4. PubMed ID: 2467496 [TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic and pharmacokinetics of BW 825C: a new antihistamine. Cohen AF; Hamilton MJ; Liao SH; Findlay JW; Peck AW Eur J Clin Pharmacol; 1985; 28(2):197-204. PubMed ID: 2859204 [TBL] [Abstract][Full Text] [Related]
20. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge. Georgitis JW; Meltzer EO; Kaliner M; Weiler J; Berkowitz R Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]